Biological
Pediacel™
Pediacel™ is a biological therapy with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
100%(5 trials)
Phase Distribution
Ph phase_2
1
20%
Ph phase_4
1
20%
Ph phase_3
3
60%
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
3(60.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (20.0%)
Phase 33 (60.0%)
Phase 41 (20.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_4
Vaccinating Children After Chemotherapy
NCT02447718
completedphase_3
Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib
NCT00652951
completedphase_3
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)
NCT01839188
completedphase_2
Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants
NCT00871338
completedphase_3
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants
NCT00384059
Clinical Trials (5)
Showing 5 of 5 trials
NCT02447718Phase 4
Vaccinating Children After Chemotherapy
NCT00652951Phase 3
Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib
NCT01839188Phase 3
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)
NCT00871338Phase 2
Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants
NCT00384059Phase 3
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5